Table 3.
Outcomes of EVD Infections
| Age and Sex | EVD Indication | Drainage Duration, Days | Infection Onset, Day | Organism(s) | Antibiotic(s) | Antibiotic Duration, Days | 30-Day Outcome, mRS |
|---|---|---|---|---|---|---|---|
| 71M | Shunt failure | 2 | 1 | CoNS | Vancomycin | 10 | 6 a |
| 66M | IVH | 6 | 5 | MSSA | Nafcillin | 42 | 4 |
| 34M | IVH | 11 | 9 | CoNS | Vancomycin | 28 | 3 |
| 59M | SAH | 10 | 9 | CoNS | Vancomycin | 14 | 4 |
| 66M | SAH | 2 | 2 |
C. acnes
CoNS |
Meropenem | 10 | 4 |
| 58M | IVH | 6 | 5 | CoNS | Vancomycin | 14 | 4 |
| 65F | TBI, SDH | 3 | 3 | C. koseri | Gentamicin IT Meropenem IV |
42 | 6 a |
| 25M | IVH | 12 | 11 |
P. agglomerans
M. luteum |
Cefepime, vancomycin | 14 | 4 |
| 45M | SAH | 18 | 16 | CoNS | Vancomycin | 14 | 3 |
Note. EVD, external ventricular drain; IVH, intraventricular hemorrhage; SAH, subarachnoid hemorrhage; TBI, traumatic brain injury; SDH, subdural hematoma; CoNS, coagulase-negative staphylococci; MSSA, methicillin-sensitive Staphylococcus aureus; C. acnes, Cutibacterium acnes; C. koseri, Citrobacter koseri; P. agglomerans, Pantoea agglomerans; M. luteus, Micrococcus luteum; IT, intrathecal; IV, intravenous; mRS, modified Rankin Scale score (3=moderate disability, 4=severe disability, 6=death).
Pateint died.